Skip to main content
. Author manuscript; available in PMC: 2020 Jul 29.
Published in final edited form as: Laryngoscope. 2017 Feb 1;127(6):1334–1338. doi: 10.1002/lary.26443

TABLE III.

OS in VC and SCC Patients Treated With Adjuvant RT.

Mean*
95% Confidence Interval
T Stage (AJCC 6th ed.) Histology Estimate SE Lower Bound Upper Bound P Value
T1 Verrucous Carcinoma 90.6 24.642 42.301 138.899
SCC 109.532 3.967 101.757 117.307
Overall 109.607 3.964 101.838 117.376 0.845
T2 Verrucous Carcinoma 78.31 14.615 49.665 106.954
8070 SCC 88.803 3.293 82.35 95.257
Overall 88.882 3.281 82.451 95.312 0.563
T3 Verrucous Carcinoma 75.667 13.087 50.017 101.316
SCC 79.233 5.667 68.125 90.341
Overall 79.321 5.627 68.293 90.349 0.52
T4 Verrucous Carcinoma 59.714 9.936 40.241 79.188
SCC 79.385 3.344 72.83 85.941
Overall 79.091 3.295 72.632 85.549 0.789
Overall Overall 92.95 2.075 88.884 97.017
*

Estimation is limited to the largest survival time if it is censored.

OS = overall survival; RT radiation therapy; SCCA = squamous cell carcinoma; SE = standard error; T = tumor; VC = verrucous carcinoma.